chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first dose 9/14/2020, would like the second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1sr dose on 14th September 2020, batch number 73T27, expiry date 9th September 2022).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The pharmacist asked should patient restart the series or can she still get the second dose. The reporter did not consent to follow up.
This case was reported by a health care professional and described the occurrence of elevated liver enzymes in a female subject of unspecified age who was vaccinated with hepatitis A vaccine inactivated for prophylaxis. The subject's medical history and concurrent conditions were not reported. Concurrent medications included Atorvastatin calcium. On an unspecified date, the subject received unspecified dose of Havrix. The lot number and expiration date were not provided. At an unspecified time after vaccination with Havrix, the subject experienced elevated liver enzymes. This case was assessed as medically serious (OMIC). At the time of reporting the outcome of the event was unspecified. No additional details are available.
the day after he received his first vaccination, 10/13/2021, he started experiencing severe tension headaches and migraines that have not gone away since first injection
Pt requested covid booster dose, discussed with MD.  This writer notified to administer dose.  Covid vaccine card checked, last dose administered 10/24/2022.  Did not see notation that this dose was a bivalent booster until looked at vaccine card again to record dose administered in this office 1/12/2023.  MD notified immediately, states no harm to patient.  Pt monitored directly by this writer x 5 minutes, then directed to waiting room to wait additional 15 minutes.  No symptoms noted at 5 minute mark.  When this writer went to check on patient at 10 minute mark she had departed office.  Follow up phone call made to patient w/in 30 minutes of her departure, pt was at home, reports no side effects, adverse reactions.
Numbness and face tingling. Similar to the impact of novacaine when at the dentist.   Symptoms started with minor tingling on tongue, then went to chin, then after a short period of time covered my entire lower left side of face from chin up through jaw and into ear. Extremely minor scratching and tingling in throat.  Entire episode only lasted a few hours. Then was mostly gone.
Patient noticed diffuse red patches on trunk of body primarily on chest and stomach.  Symptoms noticed approx 24 hours following vaccination. Patient took otc Benadryl with no improvement of symptoms.
Acute pancreatitis; This is a spontaneous report from a contactable consumer (patient). A 59-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 24Mar2021 (Batch/Lot Number: EN6208) as a single dose for COVID-19 immunization. Medical history included cardiac, hypertension (HTN), and hyperlipidaemia (HLD). The patient had no known allergies. Concomitant medications included rosuvastatin calcium (CRESTOR) taken for an unspecified indication, start and stop date were not reported; esomeprazole magnesium (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) taken for an unspecified indication, start and stop date were not reported; acetylsalicylic acid (ACETYLSALICYLIC ACID) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; zolpidem (ZOLPIDEM) taken for an unspecified indication, start and stop date were not reported; and metoprolol succinate (TOPROL) taken for an unspecified indication, start and stop date were not reported. The patient had no other vaccine in four weeks. On 01Apr2021 at 06:00AM, the patient had acute pancreatitis. It was reported that the patient had no history of pancreatitis and no other known cause of developing pancreatitis. The patient was hospitalized for acute pancreatitis for 2 days. The patient had no Covid prior vaccination and was tested for Covid post-vaccination. The patient underwent lab tests and procedures which included CT scans: unknown result, labs: unknown result, and Ultrasound: unknown result on unknown dates, and Nasal swab: negative on 01Apr2021. Treatment for the event included IV fluids, pain med, CT scan, ultrasound, and labs. The event resolved on an unknown date in 2021.
Patient was given a dose of Pfizer at a higher than authorized dose.  The saline was not mixed into the vial before administering.  Therefore pt received a concentrated dose of 0.3 ml's. Pt waited his 15 min with no adverse side effects and left the clinic. Pt was called at the phone number listed and a message left for him to call the clinic back.   According to the interim recommendation on the COVID-19 vaccine administration errors and deviations sheet he should not repeat dose of Pfizer.
pt recvd vax & had redness at inject site; dx cellulitis & tx w/ atb;
hip pain; Unable to walk; pain in the hip if the bone is touched it hurts; This case was reported by a consumer via call center representative and described the occurrence of pain in hip in a 75-year-old female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 29th November 2019, the patient received Boostrix. On 29th November 2019, less than a day after receiving Boostrix, the patient experienced pain in hip, unable to walk and touch sensitivity increased. On an unknown date, the outcome of the pain in hip was recovering/resolving and the outcome of the unable to walk and touch sensitivity increased were unknown.   It was unknown if the reporter considered the pain in hip, unable to walk and touch sensitivity increased to be related to Boostrix.  Additional details were received as follows: The patient after vaccination experienced hip pain and was unable to walk. The patient stated that now at the time of reporting experiencing pain in the hip if the bone is touched it hurts. The patient was calling GSK to see if hip pain was a possible side effect of Boostrix. The patient was not sure if Boostrix caused the hip pain or not but she was going to ask her physician if her physician thought it could be related. The patient did not have the lot number of the Boostrix but did provide the pharmacy contact information. The patient got the injection in the arm but did not recall for sure if it was her left arm or right arm. The patient was not sure if the injection was given intramuscularly or subcutaneously. The patient did not want to give her MD contact information because she has recently switched doctors. The patient did not consent to follow up.
Person is reporting persistent "brain fog" post-vaccination; This is a spontaneous report received from contactable reporter(s) (Physician).  A 13-year-old male patient received BNT162b2 (BNT162B2), on 12Nov2021 as dose 1, single (Batch/Lot number: unknown) at the age of 12 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "Person is reporting persistent "brain fog" post-vaccination". It was unknown if therapeutic measures were taken as a result of feeling abnormal.  Additional information: The most recent COVID-19 vaccine was administered reported as unknown. The patient receives any other vaccines within 4 weeks prior to the COVID vaccine reported as unknown. Prior to vaccination, the patient was diagnosed with COVID-19 reported as unknown. Since the vaccination, the patient has been tested for COVID-19 reported as unknown.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Per 8/31/16 ER Attending note: Pt presented for L arm swelling/warmth/redness that began as a probable local reaction to pneumococcal vaccine now with evidence of superimposed infection. Patient discharged home with Doxycycline with instructions to follow-up in ER in 2 days for recheck. Left arm swelling/warmth/redness. Diphenhydramine 1 cap po q6hr prn, Doxycycline 1 pill po q12h x 7 days.
Got the vaccine and a week later noticed a little puffy swollen spot on my arm where the shot was given around 2-3pm.  By 9pm that night noticed more redness and puffiness.  Took a Benadryl went to sleep.  Woke up and saw it had spread to about 2in x 2in. Was tender and hurt to touch  and itched a little.  Took another Benadryl that night, seems to be going down. Keeping an eye on it.  Never had a reaction like this ever.
16-year-old male with no significant past medical history who presented on 5/25/2021 with 2-day history of chest pain. Patient had his second dose of Pfizer Covid vaccine on 5/22/2021 and on 5/23/2021 he developed  headache and body aches.  In the afternoon of that same day patient developed retrosternal chest pain that he described as a pressure and radiated to the back.  He took 2 Tylenols and went to sleep and he reports improvement of the pain.  He woke up the next day on 5/24/2021 without any pain and was most of the day doing well but in the afternoon early evening the pain returned stronger.  He describes as at least 5 out of 10 in severity, no shortness of breath but the pain got worse when yawning or taking a deep breath.  The pain would improved if he lay on his left side.  Given the symptoms he was taken to outside hospital where he was found to have ST segment elevation and elevated troponin concerning for myo/pericarditis he was transferred from this facility for further management.  He was given 2 aspirins and the pain improved down to a 1 out of 10 and has remained the same.  Interval history 05/26/2021: No acute events overnight. Denies chest pain, SOB, or headache. Eating well. VSS. No emesis. Almost back to baseline very minimal residual discomfort
FAINTING; INCREASED BREATHING; LIGHTHEADEDNESS/DIZZINESS; NAUSEA; This spontaneous report received from a consumer concerned multiple patients (18). The reporter saw this information on the news.  The patients' weight, height, and medical history were not reported.  The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, 18 patients experienced fainting, increased breathing, dizziness/lightheadedness, and nausea. 4 out of the 18 patients went to the hospital.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nausea, lightheadedness/dizziness, fainting and increased breathing was not reported.. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210420362.; Sender's Comments: V0-20210420809-covid-19 vaccine ad26.cov2.s -Fainting. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
headache- sore throat- cough- chills- shortness of breath- body aches- loss of taste- loss of smell- sinus congestion- nasal congestion- post nasal drainage- wheezing. starting 11/29/21
experienced a little sore in the arm after the first dose; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A female patient of an unspecified age received first dose of COVID-19 vaccine (UNSPECIFIED TRADE NAME), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced a little sore in the arm after the first dose on an unspecified date with outcome of unknown.  Information on lot number/batch number has been requested.
Localized redness, swelling, tender to touch.  Hard nodule at injection site.
09/14/22 presents to EC ED for "corana virus concern". PMHx of "CKD, Multiple sclerosis, CHF"
got COVID-19; got COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "got COVID-19".  Clinical course: The reporter stated her ex-husband and his girlfriend received the Pfizer covid-19 vaccines and later got COVID-19. The reporter did not report when and how many of the Pfizer covid-19 vaccinations her ex-husband or the girlfriend of her ex-husband received.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt complained of DB, began coughing. Pt was treated by EMT and given O2. Pt breathing returned to normal after O2. Vitals were normal.
Patient passed out while waiting the 15 minutes wait period after receiving his shot.  He later reported that he passes out when nervous.  Minutes after while under observation, he also vomited but then felt better and was able to leave with family member after approximately a 30 minute observation period.
9 X 10 cm, red warm induration Treatment: Keflex 250 mg three times a day.
First symptoms were 2 huge glands directly behind left ear and 1 behind right ear. A second one came up behind the right ear later. Skin had random extreme itching in patches especially the neck (this was treated with ingesting tumeric). Jaw looked more rounded however glands in neck were not swollen. Bits of fatigue set in periodically. Taste changed and required a lot of salt on food. 1 week into symptoms 3 spots occurred on pallet/back of throat that were extremely painful, tonsils swelled like golf balls and were covered in numerous streams of thick white pus. Neck glands were swollen. Watery stool. Gas. Bloating. Sore stomach. Increased water retention/weight gain. Extreme insomnia and irritability. No medication was taken. Only raw garlic, ginger tea and tumeric were used as well as an alkalinizer. Symptoms started to ease from Jan 16th and I felt back to normal around Jan 19th 2018.
3/15 13:30 Tightness in right shoulder about 30 minutes after application. 21:00 Burning in lower back and hips.  23:00 Burning extending down the legs and further around the core.  No swelling, but almost as though nerves are being stimulated.  Chills.  Pain at a 6. 3/16 Same burning in joints down legs, pain still at 6. Persistent with low dosage of Tramadol.   3/17 02:00 still burning, with pain generalized in the hips, back and legs.  Still at a pain level of 6
Patient states that last night she started having chills, shaking, nausea and a cramp under her ribs.  This morning she said that that was all better but she had a fever of 99.  Instructed patient to continue to monitor and to go in hospital if symptoms worsen or any chest pain or shortness of breath occur.
Exhaustion, fever of 102 F. for 3 days, chills and inability to stop shaking, joint pain, muscle spasms, RA flare, rosacea breakout.
itching all over.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 02Apr2021 at 09:00(at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received codeine (MANUFACTURER UNKNOWN) on an unspecified date for an unspecified indication and experienced drug allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:00 the patient experienced itching all over. The patient did not receive any treatment for the reported adverse event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event itching all over was recovering at the time of this report   No follow-up attempts are needed. No further information is expected.
Next day had high fever up to 104 degree F , fatigue, and chills. Lasted 2 days and recovered. Day 4 after injection had itching and swelling of upper left arm. Noticeable irritation at injection site and also at smallpox vaccination site from 66 years ago. Applied witch hazel to relieve pain and itching. Lasted 2 days and recovered.
Had shot Monday (7/30) 2nd dose. Inj. on (L) arm results in progressively worsening redness and soreness w/swelling. (R) shoulder blade results in tingling pins and needles. No fever.
This spontaneous prospective pregnancy report as received from a consumer (patient's husband) for (Merck) VARIVAX a Pregnancy Registry Product, refers to a female patient of unknown age. On 22-MAR-2013, the patient was vaccinated with a dose of (Merck) VARIVAX (lot number, expiration date, dose, route were not reported). On 07-APR-2013 the patient learned that she was pregnant. The last menstrual period (LMP) and estimated delivery date (EDD) was not known. The pregnancy outcome was outcome pending. No adverse effects were reported. Follow up information has been received on 24-NOV-2014. On 06-NOV-2014 and on 13-NOV-2014 a phone calls was placed to the physician but the physician was unavailable at this time. On 24-NOV-2014 another phone call was placed to the physician. The receptionist stated that the patient was 19 year old female and had positive pregnancy test on 08-APR-2013. It was the patient's last appointment with this physician's office. The pregnancy outcome was unknown. No further information is available. Patient demographics, laboratory tests and Narrative were updated. Additional information is not expected.
Pt was given diluent and not the vaccine. I didn't realize that it needed to be reconstituted.
Flu like symptoms Sore muscles.  Sore joints. Fatigue. Exhaustion. Loose stools. Lack of thirst, even when dehydrated.
MMR 8/27/15. 9-1-15 phone call - fever - T=107 - to ER. 9-2-15 office visit - f/u ER - fever poss roseola. 9-3-15 phone call - fever and N/V (T=105). 9-4-15 OV - fever - labs CBC/CRP. 9-4-15 phone calls - CBC -> viral.
1 days p/vax pt devel inj site rxn characterized by redness, swelling & pain;pain radiated down arm;pt seen in ER & recovered p/4-5days;
I had a sore arm initially which went away. Then I developed a red, warm, swollen arm which measured 22-4 cm in size.  This latent reaction occurred 5-7 days after the injection and took another 5 days to be resolved.
Patient felt dizzy and vomited after the shot he felt hot and was sweating . Patient got shot at 14.40 and he started feeling dizzy at 14.45. After he vomited he started feeling better and he sat down for 5 to 10 minutes then he left. Per patient he was feeling good.
Developed fatigue, weakness, elevated temp (100.0F), a vomiting on day of injection. Over next 4 days, continued to have worsening weakness and felt short of breath, not improving much with albuterol inhaler. went to PCP's office on 03/09/2021 and had labs, then proceeded to ER due to extreme weakness. Was found to have elevated liver function tests at PCP's office and hospital. Also had slight  leukopenia which is chronic for the patient. Was admitted and treated with supportive treatment (IV fluids) and discharged home on 03/11/2021. Used walker for next few days before all symptoms resolved. Follow-up appt on 4/28/2021 had repeat labs showing resolution of elevated transaminases.
The patient had swelling, redness and heat at the site of injection. She went to a physicians office where they made the diagnosis of cellulitis at the site of injection.
Narrative: Patient reported to primary care clinic on 8/13/2021 with complaints of nasal and chest congestion, generalized joint pain, and mild headache. Patient tested positive for COVID-19. Was dispositioned to home with instructions to report to ER with any worsening shortness of breath. Patient received COVID-19 vaccinations at non Facility hospital in March/April 2021 -no exact dates or lot numbers available.
after my second vaccine my chronic tinnitus is much louder; fatigue; chills; muscle aches (arms, shoulders); chest pressure on left side; tachycardia; Left outer elbow felt numb; tingling sensation; This is a spontaneous report from a contactable other hcp (patient). A 62-years-old, non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9246, Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 16Feb2021 10:30 (at the age of 62-years-old) as dose 2, single for covid-19 immunisation in school or student health clinic. The patient did not receive any recent vaccines for any other conditions within 4 weeks prior to the event being reported. The patient did not receive any recent vaccines for SARS-CoV2 other than Pfizer-BioNTech COVID-19 Vaccine prior to the event being reported. The patient did not receive any other vaccines around the time of Pfizer-Biotech COVID-19 vaccine vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Medical history included, osteoporosis, osteoarthritis, erythromelalgia, trigeminal neuralgia. Concomitant medication(s) included nortriptyline taken for trigeminal neuralgia, start and stop date were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL3246, Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 19Jan2021 14:30 (at the age of 62-years-old) as dose 1, single for covid-19 immunisation in school or student health clinic and experienced itching and swelling on left side of tongue 2.5 hrs after first vaccine. The patient previously took, nortriptyline for trigeminal neuralgia, levaquin and experienced drug hypersensitivity. On an unspecified date, after her second vaccine her chronic tinnitus was much louder. On 16Feb2021, the patient experienced left outer elbow felt numb and tingling sensation. On 17Feb2021, the patient experienced fatigue, chills, muscle aches (arms, shoulders), chest pressure on left side, tachycardia. The reported events were considered as non-serious by reporter. The outcome of the event after her second vaccine her chronic tinnitus was much louder was not recovered and all other events was recovered on 17Feb2021.  No follow-up attempts are possible. No further information is expected.